Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
30.23
-1.81 (-5.65%)
At close: Apr 15, 2025, 4:00 PM
29.97
-0.26 (-0.87%)
Pre-market: Apr 16, 2025, 4:24 AM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $3.89 billion as of April 15, 2025. Its market cap has decreased by -46.19% in one year.
Market Cap
3.89B
Enterprise Value
2.22B
1-Year Change
-46.19%
Ranking
Category
Stock Price
$30.23
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $3.89B, an increase of 182.07%. That is a compound annual growth rate of 23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2025 | 3.89B | -61.85% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.71B |
| UnitedHealth Group | 534.32B |
| Johnson & Johnson | 367.21B |
| AbbVie | 313.69B |
| Novo Nordisk | 283.15B |
| Abbott Laboratories | 221.03B |
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |